Educational and Supportive Care to Depressed Infertile Females
The Assessment of Educational and Supportive Care to the Depressed Infertile Females Undergo In Vitro Fertilization Procedure by Clinical Pharmacist: Randomized Clinical Trial
1 other identifier
interventional
150
1 country
1
Brief Summary
Infertility affects married adults, and In Vitro Fertilization (IVF) is an Assisted Reproductive Technology (ART) that can be treated. Women undergoing IVF are more likely to experience depression. There is a need to reduce depression by supporting and advising sufferers. The aim of this study is to evaluate pharmacist counseling's impact on pregnancy rates in depressed infertile females during IVF treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 25, 2023
CompletedFirst Posted
Study publicly available on registry
September 5, 2023
CompletedSeptember 5, 2023
August 1, 2023
6 months
August 25, 2023
August 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pregnancy rate
The outcome of IVF cycles, as measured by clinical pregnancy rates, was recorded after the intervention
Baseline, 1-month, 3-month, and 6-month marks following the commencement of treatment.
Secondary Outcomes (2)
Fertility Quality of Life.
Baseline, 1-month, 3-month, and 6-month marks following the commencement of treatment.
Depression status
Baseline, 1-month, 3-month, and 6-month marks following the commencement of treatment.
Study Arms (2)
Group 1
EXPERIMENTALThe study included 75 patients in the intervention group who received an educational and supportive program designed by a clinical pharmacist. The intervention group received support through five visits: at admission, monitoring medication, monitoring ovulation, monitoring harmful effects, providing emotional support, and following up after egg retrieval during embryo transfer.
Group 2
NO INTERVENTIONThe control group included 75 infertile married ladies attending the hospital for the same purpose and managed in the traditional protocol followed by the hospital system. The study assessed the fertility quality of life and depression status of the patients at the beginning and end of the IVF cycle. All patients received frozen embryo transfers (fertilized eggs), not fresh embryos.
Interventions
The trial had a total of 75 participants assigned to the intervention group, whereby they were provided with an educative and supporting program specifically developed by a clinical pharmacist. The intervention group was provided with assistance via a series of five visits, which included an initial visit upon admission, subsequent visits for monitoring medication, ovulation, and negative effects, as well as visits dedicated to giving emotional support. Additionally, a follow-up visit was conducted after the egg collecting process and embryo transfer.
Eligibility Criteria
You may qualify if:
- To be an infertile lady who spent at least one year after marriage failing to get pregnant and who should then undergo the IVF cycle.
- To be within the reproductive age (18-45 years old); the success rates of IVF tend to decline with increasing age\[4\].
- To have the ability to read and understand.
- Have depression
You may not qualify if:
- Patient with previous failure of I.V.F. procedure.
- Very obese (BMI \> 40)\[37\].
- Patient with psychiatric problems (psychiatric hospital admission, addiction, neurological or other progressive disease, and psychiatric drug use).
- A patient who has a situation that prevents communication (language and hearing problems).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Pharmacy, Mustansiriyah University
Baghdad, 10011, Iraq
Related Publications (3)
Maleki-Saghooni N, Amirian M, Sadeghi R, Latifnejad Roudsari R. Effectiveness of infertility counseling on pregnancy rate in infertile patients undergoing assisted reproductive technologies: A systematic review and meta-analysis. Int J Reprod Biomed. 2017 Jul;15(7):391-402.
PMID: 29177241BACKGROUNDAl-Homaidan HT. Depression among Women with Primary Infertility attending an Infertility Clinic in Riyadh, Kingdom of Saudi Arabia: Rate, Severity, and Contributing Factors. Int J Health Sci (Qassim). 2011 Jul;5(2):108-15.
PMID: 23267288BACKGROUNDNkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, Bero L. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010 Jul 7;2010(7):CD000336. doi: 10.1002/14651858.CD000336.pub2.
PMID: 20614422BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Abeer A Rashid, FIBMS
Al-Mustansiriyah University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2023
First Posted
September 5, 2023
Study Start
January 1, 2022
Primary Completion
July 1, 2022
Study Completion
July 1, 2022
Last Updated
September 5, 2023
Record last verified: 2023-08